Regulon

Regulon: R-1611

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
132.2785516Pr-38Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
7204 ENSG00000038382 TRIO O75962
28951 ENSG00000071575 TRIB2 Q92519
2887 ENSG00000106070 GRB10 Q13322
2034 ENSG00000116016 EPAS1 Q99814
23314 ENSG00000119042 SATB2 Q9UPW6
2181 ENSG00000123983 ACSL3 O95573
643314 ENSG00000127603 MACF1 B4DQX9
4907 ENSG00000135318 NT5E P21589
10253 ENSG00000136158 SPRY2 O43597
10427 ENSG00000138802 SEC24B O95487
636 ENSG00000151746 BICD1 Q96G01
9529 ENSG00000166170 BAG5 A0A024R6M6
25907 ENSG00000249992 TMEM158 Q8WZ71

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
OLECLUMABNT5EAntibodyINHIBITOR5'-nucleotidase inhibitor20
BELZUTIFANEPAS1Small moleculeINHIBITOREndothelial PAS domain-containing protein 1 inhibitor40

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-1611

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs
CMF-13214SLC26A8up-regulatesTCF4activatesR-1611172Drugs (2)

Regulator Drugs (0)

Regulon Drugs (2)

OLECLUMAB, BELZUTIFAN

CMF-16584RBM19down-regulatesTCF4activatesR-1611175Drugs (2)

Regulator Drugs (0)

Regulon Drugs (2)

OLECLUMAB, BELZUTIFAN

CMF-17257MAP3K7up-regulatesTCF4activatesR-1611174Drugs (2)

Regulator Drugs (0)

Regulon Drugs (2)

OLECLUMAB, BELZUTIFAN

CMF-19121LRP1Bup-regulatesTCF4activatesR-1611172Drugs (2)

Regulator Drugs (0)

Regulon Drugs (2)

OLECLUMAB, BELZUTIFAN

CMF-26761RB1down-regulatesTCF4activatesR-1611175Drugs (2)

Regulator Drugs (0)

Regulon Drugs (2)

OLECLUMAB, BELZUTIFAN

CMF-29699ESRRBdown-regulatesTCF4activatesR-1611176Drugs (2)

Regulator Drugs (0)

Regulon Drugs (2)

OLECLUMAB, BELZUTIFAN